Olivier Taelman

Chief Executive Officer bij NYXOAH SA

Vermogen: 6 M $ op 31-03-2024

54 jaar

Health Technology

Consumer Services

Electronic Technology

Actieve functies van Olivier Taelman

Bedrijven	Functie	Begin	Einde
NYXOAH SA	Director/Board Member	01-09-2020	-
	Chief Executive Officer	01-11-2019	-
	Chief Operating Officer	01-07-2019	01-11-2019

Bedrijven	Functie	Begin	Einde
Autonomic Technologies, Inc. Autonomic Technologies, Inc. Electronic Equipment/InstrumentsElectronic Technology Autonomic Technologies, Inc. develops and commercializes innovative therapies for the treatment of severe headache. Its product, the ATI Neurostimulation System, is used for the treatment of acute pain of cluster headache. The company was founded in 2007 and is headquartered in Redwood City, CA.	Corporate Officer/Principal	01-12-2015	01-11-2019
NEVRO CORP.	Corporate Officer/Principal	01-12-2013	01-12-2015

Hasselt University	Undergraduate Degree
The Wharton School of the University of Pennsylvania	Masters Business Admin

Internationaal

Verenigde Staten	4
België	3

Operationeel

Corporate Officer/Principal	2
Director/Board Member	1
Chief Executive Officer	1

Sectoraal

Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Beursgenoteerde bedrijven	2
NEVRO CORP.	Health Technology
NYXOAH SA	Health Technology

Bedrijven in privébezit	1
Autonomic Technologies, Inc. Autonomic Technologies, Inc. Electronic Equipment/InstrumentsElectronic Technology Autonomic Technologies, Inc. develops and commercializes innovative therapies for the treatment of severe headache. Its product, the ATI Neurostimulation System, is used for the treatment of acute pain of cluster headache. The company was founded in 2007 and is headquartered in Redwood City, CA.	Electronic Technology

Bedrijven in privébezit

Electronic Technology